CPH
GILD icon

C Partners Holding’s Gilead Sciences GILD Stock Holding History

C Partners Holding’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,526
Closed -$118K – 100
2018
Q3 		$118K Sell
1,526
-1,461
-49% -$110K 0.04% 151
2018
Q2 		$212K Buy
2,987
+329
+12% +$23.2K 0.08% 208
2018
Q1 		$200K Sell
2,658
-843
-24% -$67K 0.08% 206
2017
Q4 		$251K Buy
+3,501
New +$266K 0.1% 221
2015
Q2 		– Sell
-37,600
Closed -$3.69M – 45
2015
Q1 		$3.69M Buy
37,600
+5,000
+15% +$508K 1.18% 22
2014
Q4 		$3.07M Buy
+32,600
New +$3.37M 1% 30

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

C Partners Holding's GILD Position: Q4 2018 in Review

C Partners Holding sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 1,526 shares — an estimated $118K sold.

C Partners Holding first reported a position in GILD in Q4 2014 and held it in 6 quarters. The position peaked at $3.69M in Q1 2015. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • C Partners Holding reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • C Partners Holding sold 1,526 Gilead Sciences shares in Q4 2018, an estimated $118K.
  • C Partners Holding first reported a position in Gilead Sciences in Q4 2014 and held it in 6 quarters.
  • C Partners Holding's Gilead Sciences position peaked at $3.69M in Q1 2015.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on C Partners Holding's 13F filing for Q4 2018, filed 7 Feb 2019.